Coronavirus (COVID-19) and Cardiovascular Disease
The Coronavirus (COVID-19) pandemic continues to spread across all countries and is increasingly posing significant health and economic risk to millions of Australians. This infectious…
Author: Medd
New Findings for Left Ventricular Assist Device Patients
A recent study by Structural Heart found that left ventricular assist device patients who later develop moderate to severe aortic regurgitation may benefit from the option to…
TAVI, SAVR and the Economic Impact
Associate Professor Dion Stub, Hope For Hearts and MEDD contributor, shares his views on the challenges for patients with aortic stenosis accessing new treatment technologies.…
Australian Cardiologists won’t miss a beat with new heart technology
A new generation of implantable cardiac devices with heart failure diagnostics are enabling Australian cardiologists to better predict the development of heart failure, potentially weeks…
Heart Failure Guidelines Explained – Dr John Hayes from St Andrew’s War Memorial Hospital
Considerations for General Practitioners Seeing Heart Failure Patients Heart failure (HF) affects almost half a million adults in Australia, with this number projected to increase…
Low-risk patients and TAVI
Partner 3 Trial shows new clinical data suggesting that TAVI may benefit more patients with Aortic Stenosis Aortic Stenosis is a common heart valve condition…
